Characterization of the Subventricular-Thalamo-Cortical Circuit in the NP-C Mouse Brain, and New Insights Regarding Treatment

Mol Ther. 2019 Aug 7;27(8):1507-1526. doi: 10.1016/j.ymthe.2019.05.008. Epub 2019 May 16.

Abstract

Gliosis in Niemann-Pick type C (NP-C) disease is characterized by marked changes in microglia and astrocytes. However, the gliosis onset and progression in NP-C has not been systematically studied, nor has the mechanism underlying this finding. Here, we found early gliosis in the subventricular zone (SVZ) of NP-C mice. Neural progenitor damage by Npc1 mutation suppressed vascular endothelial growth factor (VEGF) expression and further induced microglia activation followed by astrogliosis. Interestingly, excessive astrogliosis in the SVZ induced neural progenitor retention and/or migration into thalamus via astrocyte-derived VEGF, resulting in acceleration of thalamic and cortical gliosis through thalamo-cortical pathways. Transplantation of VEGF-overexpressing neural stem cells into the SVZ improved whole-brain pathology of NP-C mice. Overall, our data provide a new pathological perspective on NP-C neural pathology, revealing abnormalities in the subventricular-thalamo-cortical circuit of NP-C mouse brain and highlighting the importance of the SVZ microenvironment as a therapeutic target for NP-C disease.

Keywords: Niemann-Pick type C disease; gliosis; neural progenitor retention and/or migration; subventricular zone; thalamo-cortical pathway; vascular endothelial growth factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Astrocytes / metabolism
  • Biomarkers
  • Cell Movement
  • Cerebral Cortex / metabolism*
  • Disease Models, Animal
  • Gliosis / etiology
  • Gliosis / metabolism
  • Gliosis / pathology
  • Lateral Ventricles / metabolism*
  • Mice
  • Microglia / metabolism
  • Neural Stem Cells / metabolism
  • Niemann-Pick Disease, Type C / etiology
  • Niemann-Pick Disease, Type C / metabolism*
  • Niemann-Pick Disease, Type C / pathology
  • Niemann-Pick Disease, Type C / therapy
  • Signal Transduction*
  • Thalamus / metabolism*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Biomarkers
  • Vascular Endothelial Growth Factor A